Role of biliary phosphatidylcholine in bile acid protection and NSAID injury of the ileal mucosa in rats

被引:80
作者
Barrios, JM
Lichtenberger, LM
机构
[1] Univ Texas, Sch Med, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
关键词
D O I
10.1016/S0016-5085(00)70371-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: We explored the role of biliary phosphatidylcholine (PC) in protection of the intestinal mucosa against bile salt (BS)-induced intestinal injury and how this property may be blocked by indomethacin (Indo), a nonsteroidal anti-inflammatory drug (MSAID) that is secreted into the bile. Methods: We performed in vivo studies in which bile was collected over a 2-hour period after rats were intragastrically administered Indo (25 mg/kg) or an equivalent volume of saline (controls). The bile samples (some of which were supplemented with PC) were then instilled into a loop of distal ileum of anesthetized rats. After a 30-minute exposure period, we measured the hemoglobin concentration of the ileal loop fluid, as an index of bleeding, and mucosal contact angles, as an index of surface hydrophobicity. A similar in vivo experiment was performed in which model bile containing 5 mmol/L each of the BS, sodium deoxycholate, PC, or Indo, alone and in combination, was instilled into ileal loops. In our in vitro test system, human erythrocytes were exposed to the above biliary constituents, and hemolysis was measured spectrophotometrically. Results: Bile from Indo-pretreated rats decreased the surface hydrophobicity and induced bleeding of ileal loops in comparison with control bile, and both NSAID-induced changes were reversed if PC was added to the bile. Similarly, synthetic BS caused gastrointestinal bleeding, decreased ileal contact angles, and induced erythrocyte hemolysis, all of which were reversed by addition of equimolar PC. This protective role of PC in both the in vivo and in vitro systems was partially blocked by Indo, although the NSAID had no effect on these properties on its own. Conclusions: These findings support the hypothesis that PC protects the intestinal mucosa against injurious actions of BS, possibly by forming less toxic mixed micelles. Indo and perhaps other NSAIDs that enter the bile may damage the mucosa, not by a direct action, but by competing for the available protective PC molecules.
引用
收藏
页码:1179 / 1186
页数:8
相关论文
共 37 条
[1]
GASTRODUODENAL MUCOSAL PROTECTION [J].
ALLEN, A ;
FLEMSTROM, G ;
GARNER, A ;
KIVILAAKSO, E .
PHYSIOLOGICAL REVIEWS, 1993, 73 (04) :823-857
[2]
GASTRIC-MUCOSAL TOXICITY OF DUODENAL JUICE CONSTITUENTS IN THE RAT - ACUTE STUDIES USING EX-VIVO RAT GASTRIC CHAMBER MODEL [J].
ARMSTRONG, D ;
RYTINA, ERC ;
MURPHY, GM ;
DOWLING, RH .
DIGESTIVE DISEASES AND SCIENCES, 1994, 39 (02) :327-339
[3]
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[4]
MEMBRANE LIPID-COMPOSITION AND SUSCEPTIBILITY TO BILE-SALT DAMAGE [J].
COLEMAN, R ;
LOWE, PJ ;
BILLINGTON, D .
BIOCHIMICA ET BIOPHYSICA ACTA, 1980, 599 (01) :294-300
[5]
MEMBRANES AND BILE FORMATION - COMPOSITION OF SEVERAL MAMMALIAN BILES AND THEIR MEMBRANE-DAMAGING PROPERTIES [J].
COLEMAN, R ;
IQBAL, S ;
GODFREY, PP ;
BILLINGTON, D .
BIOCHEMICAL JOURNAL, 1979, 178 (01) :201-208
[6]
RELEASE OF MEMBRANE COMPONENTS PRIOR TO HEMOLYSIS DURING EXTRACTION OF INTACT ERYTHROCYTES WITH BILE-SALTS [J].
COLEMAN, R ;
HOLDSWORTH, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1976, 426 (04) :776-780
[7]
BILE-ACID AND BILE-SALT DISRUPT GASTRIC-MUCOSAL BARRIER IN THE DOG BY DIFFERENT MECHANISMS [J].
DUANE, WC ;
WIEGAND, DM ;
SIEVERT, CE .
AMERICAN JOURNAL OF PHYSIOLOGY, 1982, 242 (02) :G95-G99
[8]
MECHANISM BY WHICH BILE-SALT DISRUPTS THE GASTRIC-MUCOSAL BARRIER IN THE DOG [J].
DUANE, WC ;
WIEGAND, DM .
JOURNAL OF CLINICAL INVESTIGATION, 1980, 66 (05) :1044-1049
[9]
EL-HARIRI L M, 1988, Journal of Pharmacy and Pharmacology, V40, p13P
[10]
THE MITIGATING EFFECTS OF PHOSPHATIDYLCHOLINES ON BILE SALT-INDUCED AND LYSOPHOSPHATIDYLCHOLINE-INDUCED MEMBRANE DAMAGE [J].
ELHARIRI, LM ;
MARRIOTT, C ;
MARTIN, GP .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1992, 44 (08) :651-654